AI assistant
Vericel Corp — Director's Dealing 2024
Feb 22, 2024
31799_dirs_2024-02-22_84b1cd28-7de4-447d-bf57-a44c2f7d9eac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2024-02-20
Reporting Person: Halpin Michael (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-20 | Common Stock | M | 5250 | — | Acquired | 7917 | Direct |
| 2024-02-20 | Common Stock | F | 2587 | $49.5 | Disposed | 5330 | Direct |
| 2024-02-20 | Common Stock | M | 3825 | — | Acquired | 9155 | Direct |
| 2024-02-20 | Common Stock | F | 1812 | $49.5 | Disposed | 7343 | Direct |
| 2024-02-20 | Common Stock | M | 2812 | — | Acquired | 10155 | Direct |
| 2024-02-20 | Common Stock | F | 1332 | $49.5 | Disposed | 8823 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | Restricted Stock Unit | $ | M | 5250 | Acquired | Common Stock (5250) | Direct | |
| 2024-02-20 | Restricted Stock Unit | $ | M | 3825 | Acquired | Common Stock (3825) | Direct | |
| 2024-02-20 | Restricted Stock Unit | $ | M | 2812 | Acquired | Common Stock (2812) | Direct |
Footnotes
F1: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively.
F2: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F3: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
F4: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively.
F5: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025.
F6: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F7: No expiration date for this type of award.
F8: The Fair Market Value of the vested derivative securities is $49.50 per share.